Market Entry of Molecular diagnostic product of a Tier 1 Japanese Diagnostic Company in the USA, and EU4. The diagnostic kit was best in quality and priced premium. The client was concerned that it might face resistance in the said markets. My team connected with the decision makers and distributors in the selected market and planned a pre-market entry strategy. The entire exercise was conducted using a mix of primary and secondary research. Emplanelled Key opinion leaders were engaged to influence the market leaders and regulators. Necessary marketing budget was spent to create the right noise before the market launch. The diagnostic kit was launched in a phase wise manner from year X to 2021. The client had a successful launch in the west and engaged us for many more market entry exercises.

Competitive Intelligence of COVID-19 Vaccines - The client was one of the top vaccine manufacturers from Europe, who had tied up with the US based Pharma giant to manufacture vaccines for western world and later sell it to African nations and third world countries. My team created a CI network tracking 27 nations every day for regulatory approvals, peer movement, stock purchase, stock damaged, pricing trends, public sentiments, tendering process by respective governments and peer vaccine pipeline which were expected to enter the same market in following months. My team created CI visualizations for the C levels (Client's company) and helped them track the market movements real time. The CI dashboard helped them track their own market movement versus peers and helped them stay ahead in the competition. Due to the timely alerts and market movement, the client registered high profits during the period of 2021-2022.